CAPCHEM(SZ:300037) Soochow Securities·2026-02-11 05:47Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a total revenue of 9.638 billion yuan in 2025, representing a year-on-year increase of 22.82% [7] - The estimated net profit attributable to shareholders for 2025 is 1.098 billion yuan, reflecting a year-on-year growth of 16.54% [7] - The report highlights that the price increase of hexafluoropropylene has contributed significantly to profit recovery, with a projected profit contribution of around 1 billion yuan from the electrolyte segment in Q4 2025 [7] - The company anticipates a robust growth in the fluorochemical sector, with an estimated profit contribution of approximately 10 billion yuan in 2026 [7] Financial Projections - Total revenue projections for the company are as follows: - 2023: 7.484 billion yuan - 2024: 7.847 billion yuan - 2025: 9.638 billion yuan - 2026: 13.719 billion yuan - 2027: 16.947 billion yuan [1][8] - Net profit attributable to shareholders is projected to be: - 2023: 1.011 billion yuan - 2024: 942 million yuan - 2025: 1.098 billion yuan - 2026: 2.397 billion yuan - 2027: 2.985 billion yuan [1][8] - The report estimates the earnings per share (EPS) to be: - 2023: 1.34 yuan - 2024: 1.25 yuan - 2025: 1.46 yuan - 2026: 3.19 yuan - 2027: 3.97 yuan [1][8] Market Data - The closing price of the company's stock is 50.88 yuan, with a market capitalization of approximately 38.251 billion yuan [5] - The price-to-earnings (P/E) ratio is projected to be 34.84 for 2025 and 15.96 for 2026 [1][8] - The company has a net asset value per share of 13.40 yuan [6]